Chargement en cours...
Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
Prostate cancer is the second deadliest cancer in the US and the fourth most common cancer among Saudi males. Patients usually present with non-metastatic disease and treated with localized therapy. However, up to 40% of the patients will experience biochemical recurrence, within 10 years. Androgen...
Enregistré dans:
| Publié dans: | Saudi Pharm J |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6438706/ https://ncbi.nlm.nih.gov/pubmed/30976180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2018.12.005 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|